All tuberculosis articles
-
NewsDecoding the WHO Global Tuberculosis Report 2024: A critical analysis of global and Chinese key data
A new paper provides an in-depth interpretation of the WHO Global Tuberculosis Report 2024, analyzes global TB trends, updates the status of drug-resistant TB, discusses the intersection between TB and HIV, and summarizes the implications of the pandemic on TB control efforts.
-
NewsSystem to auto-detect new variants will inform better response to future infectious disease outbreaks
Researchers have come up with a new way to identify more infectious variants of viruses or bacteria that start spreading in humans - including those causing flu, COVID, whooping cough and tuberculosis.
-
NewsPeat-bog fungi produce substances that kill tuberculosis-causing bacteria
An analysis of fungi collected from peat bogs has identified several species that produce substances toxic to the bacterium that causes the human disease tuberculosis.
-
NewsUnderstanding neonatal infectious diseases in low- and middle-income countries
Researchers have conducted an in-depth study on the epidemic status, secular trends, and risk factors of 15 common neonatal infectious diseases across low- and middle-income countries (LMICs) from 1990 to 2019.
-
NewsRule-breaking tuberculosis bacteria challenge growth norms
The rod-shaped tuberculosis (TB) bacterium is the first single-celled organism ever observed to maintain a consistent growth rate throughout its life cycle, a new study reports, hinting at why the pathogen so readily outmaneuvers our immune system and antibiotics.
-
NewsResearchers reveal why a key tuberculosis drug works against resistant strains
Research has uncovered why a relatively new antibiotic for tuberculosis (TB) works against multidrug-resistant strains, potentially inspiring improved treatments and drug development strategies.
-
NewsStudy identifies ‘Achilles heel’ of drug-resistant pathogens
A study has found a highly vulnerable weakness in drug-resistant Mycobacterium tuberculosis, using a genetic platform to identify biological pathways in a drug-resistant strain of the bacterium that are highly sensitive to inhibition.
-
NewsResearchers seek out shorter, simpler TB treatments
Scientists are working to develop treatment options for tuberculosis that require fewer pills, shorter treatment periods (ideally 2-3 months), and consist of 3-4 medications that reduce the risk of resistance while minimizing toxicity.
-
News10% of children in high-burden tuberculosis settings may develop the disease by age 10
A new study finds a high risk of tuberculosis infection and disease in children up to 10 years old who live in areas where TB spread is common.
-
NewsTuberculosis changes liver metabolism and could promote diabetes
Scientists have discovered that tuberculosis disrupts glucose metabolism in the body and can promote progress to diabetes.
-
NewsBetter use of vaccines could reduce antibiotic use by 2.5 billion doses annually, says WHO
A new report finds that vaccines against 24 pathogens could reduce the number of antibiotics needed by 22% or 2.5 billion defined daily doses globally every year, supporting worldwide efforts to address antimicrobial resistance (AMR).
-
NewsStudy identifies potential novel drug to treat tuberculosis
A new study demonstrates that a novel semi-synthetic compound can be derived from natural compounds to produce potent activity against Mycobacterium tuberculosis, including multi-drug resistant strains.
-
NewsPlant compound used in traditional medicine may help fight tuberculosis
A compound found in African wormwood — a plant used medicinally for thousands of years to treat many types of illness — could be effective against tuberculosis, according to a new study.
-
NewsResearchers discover mechanism driving immune perturbations after severe TB infections
Rsearchers have discovered a mechanism that drives the long-term decline in immune response that is observed after tuberculosis (TB) has been successfully treated.
-
NewsPromising TB therapy safe for patients with HIV
A therapy showing promise to help control tuberculosis (TB) does not interfere with combined antiretroviral therapy (cART), according to new research.
-
NewsStudy finds outbreak detection under-resourced in Asia
A two-year assessment provides critical insights and recommendations for strengthening genomic sequencing for infectious disease surveillance in 13 South and Southeast Asian countries.
-
NewsNew findings on TB could change how we treat inflammatory disorders
Researchers have found rare mutation that leaves its carriers much more likely to become ill with TB—but, curiously, not with other infectious diseases, potentially upending long-held assumptions about the immune system.
-
NewsImmune protection against tuberculosis reinfection driven by cells that dampen lung inflammation
The body’s first line of defense against tuberculosis (TB) involves immune cells that suppress lung inflammation instead of activating it, scientists report.
-
NewsNIH grant establishes UAB’s Global Research Resource for Human Tuberculosis
A $5.8m grant led by Adrie Steyn, Ph.D., of the University of Alabama at Birmingham and the Africa Health Research Institute, or AHRI, in Durban, South Africa, will provide user-requested infected human lung tissue and analytical services to tuberculosis researchers worldwide.
-
NewsStudy highlights factors associated with higher tuberculosis risk in South Africa
Tuberculosis is the world’s top infectious killer. About 10 million people fall ill with the disease every year, and roughly 1.5 million people die because of it, according to the World Health Organization. Additionally, about one-quarter of the world’s population is infected with the disease’s causative agent Myctuberobacterium tuberculosis. ...
